Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.08.2018 | Case report

Foscarnet/ganciclovir/valganciclovir

Hamatological toxicity: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective observational study of 203 patients, seven patients 1 [ages and sexes not stated] were described, who developed haematological toxicity during treatment with ganciclovir (5 patients), valganciclovir (1 patient) or foscarnet (1 patient) for cytomegalovirus (CMV) infection [routes, dosages and outcomes not stated]. …
Fußnoten
1
"Out of 14 identifiable patients, only 7 patients developed an ADR."
 
Literatur
Zurück zum Zitat Solano C, et al. Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: When should genotypic drug resistance testing be requested?. Bone Marrow Transplantation 53: 787-790, No. 6, Jun 2018. Available from: URL: http://doi.org/10.1038/s41409-018-0191-8 - Spain Solano C, et al. Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: When should genotypic drug resistance testing be requested?. Bone Marrow Transplantation 53: 787-790, No. 6, Jun 2018. Available from: URL: http://​doi.​org/​10.​1038/​s41409-018-0191-8 - Spain
Metadaten
Titel
Foscarnet/ganciclovir/valganciclovir
Hamatological toxicity: 7 case reports
Publikationsdatum
01.08.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-50006-z

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Camrelizumab

Case report

Nivolumab

Case report

Multiple drugs

Case report

Prednisolone